Bank of America’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $357K | Buy |
144,511
+31,585
| +28% | +$78K | ﹤0.01% | 4967 |
|
2025
Q1 | $225K | Sell |
112,926
-317,687
| -74% | -$632K | ﹤0.01% | 5148 |
|
2024
Q4 | $1.26M | Sell |
430,613
-54,512
| -11% | -$159K | ﹤0.01% | 4072 |
|
2024
Q3 | $1.88M | Buy |
485,125
+57,729
| +14% | +$223K | ﹤0.01% | 3891 |
|
2024
Q2 | $2.2M | Buy |
427,396
+5,976
| +1% | +$30.7K | ﹤0.01% | 3725 |
|
2024
Q1 | $2.95M | Sell |
421,420
-49,176
| -10% | -$344K | ﹤0.01% | 3472 |
|
2023
Q4 | $4.17M | Buy |
470,596
+167,954
| +55% | +$1.49M | ﹤0.01% | 3064 |
|
2023
Q3 | $2.89M | Buy |
302,642
+155,127
| +105% | +$1.48M | ﹤0.01% | 3273 |
|
2023
Q2 | $2.16M | Sell |
147,515
-2,752
| -2% | -$40.3K | ﹤0.01% | 3503 |
|
2023
Q1 | $1.85M | Buy |
150,267
+102,908
| +217% | +$1.27M | ﹤0.01% | 3765 |
|
2022
Q4 | $880K | Buy |
+47,359
| New | +$880K | ﹤0.01% | 4295 |
|